The HCPLive pain page is a resource for medical news and expert insights on pain medicine. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for acute pain, chronic pain, addiction medicine, and more.
April 29th 2024
FDA issued a CRL the abbreviated new drug application of ketamine, which had sought to enhance accessibility to the limited drug supply.
Advancing Care in Erosive Esophagitis: Towards a Path of Complete Healing
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 18, 2024
Register Now!
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
NBA Basketball Eight Days after Meniscus Surgery!
April 26th 2010Brandon Roy of the Portland Trail Blazers in the NBA played tonight in game 4 of the Blazers playoff series with the Phoenix Suns. To those of you who are not sports fans, you may say, "So what?" The amazing thing is that Roy had arthroscopic surgery for a torn meniscus eight days ago.
Chronic Pain Suffering Leads to High Risks of Depression for Black Men
April 16th 2010Among male chronic pain sufferers, Black men are more likely to experience depression, affective distress, and disability than white men, according to study results published in the Journal of the National Medical Association.
Why the iPad Will Not Be Used for Healthcare IT
April 15th 2010Some health care IT industry heavyweights have gone so far as to suggest that the iPad will be greatly utilized in the healthcare setting and revolutionize the way we do business. While I do think the iPad is incredibly shiny and is great computer replacement for your grandma, I think it's a bit of an exaggeration to suggest that it will ever be fully adopted by healthcare IT shops.
Hyperchondriasis - a "New Age" Somatoform Disorder
April 13th 2010Modern medicine's technological advances now allow more people to live long enough to develop chronic diseases where the mortality is low but the morbidity high. Hyperchondriacs are acutely aware of this, and perceive great threats in their aging and the future. Hyperchondriacs have similar attributes to hypochondrial patients even as they lack the attendant "symptoms" of a physiologic illness.
Will the iPad Create Solutions in Healthcare?
The highly coveted iPad was released last weekend, and those who were fortunate enough to acquire the new gadget have been quick to discuss what kind of impact it will have on just about any industry. But what kind of impact will the iPad have on healthcare?
Self-administered Oral Migraine Treatment Receives More Testing
April 8th 2010An orally-inhaled migraine therapy known as LEVADEX has entered into a pharmacodynamics (PD) trial. The acute effect of LEVADEX, produced by MAP Pharmaceuticals, Inc, will be compared to intravenous dihydroergotamine mesylate (IV DHE) and placebo on pulmonary artery pressure.
Is Healthcare Reform Meaningless without Tort Reform?
March 31st 2010Individuals across the country are either rejoicing, cursing, or anxious over the historic passing of healthcare reform legislation and for physicians and legal experts alike the question remains: What will these changes mean for the practice of medicine and patients' rights?